Bayer, OncoMed collaborate to develop anti-cancer stem cell therapeutics to target Wn
Bayer Schering Pharma AG and OncoMed Pharmaceuticals, Inc., today announced a global strategic alliance to discover, develop and commercialize novel anti-cancer stem cell therapeutics targeting the Wnt signaling pathway.